[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].
D014150:Antipsychotic Agents; D006801:Humans; D009422:Nervous System Diseases; D010640:Phenothiazines / Q000031:analogs & derivatives; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D013577:Syndrome
D014150:Antipsychotic Agents; D010640:Phenothiazines; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; C031637:phenothiazine
NERVOUS SYSTEM/diseases; PHENOTHIAZINE/related compounds; SULFONAMIDES/therapeutic use
Syndromes neurologiques expérimentaux et thérapeutique psychiatrique. I. Effets neurologiques d'un nouveau neuroleptique majeur, le 7843 RP.